Newsletter Archive

1. 04.30.25 -- Advance Your mAb Program's Success 4/30/2025
   04/30/25
2. 04.30.25 -- Do Patient Needs Define Biologic Product Specifications? 4/30/2025
   04/30/25 Bioprocess Online Newsletter
3. 04.29.25 -- Trends In U.S. Biomanufacturing: From Cell Line Development To Commercial Scale 4/29/2025

   04/29/25 Bioprocess Online Newsletter

4. 04.29.25 -- Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers 4/29/2025
   04/29/25 Bioprocess Online Newsletter
5. 04.28.25 -- Ramping Up GMP-Compliant CAR-NK Manufacturing At Scale With iPSCs 4/28/2025
   04/28/25 Bioprocess Online Newsletter
6. 04.25.25 -- STREAM Edition: Environmental Sustainability In Bioprocessing 4/25/2025

   04/25/25 Bioprocess Online Newsletter

7. 04.25.25 -- Climbing The Blockchain Ladder To Optimize Clinical Supply Forecasting 4/25/2025
   04/25/25 Bioprocess Online Newsletter
8. 04.24.25 -- Unlock T-Cell Potential: Gamma Delta Insights, New Media, And Non-Viral Methods 4/24/2025

   04/24/25 Bioprocess Online Newsletter

9. 04.24.25 -- Pharmaceutical Sovereignty: The Resilience We Cannot Outsource 4/24/2025
   04/24/25 Bioprocess Online Newsletter
10. 04.23.25 -- Accelerating Bioprocessing: Smarter DSP, Analytics, And Scale-Up 4/23/2025
    04/23/25 Bioprocess Online Newsletter